Naltrexone Hydrochloride Loaded W/O Microemulsions: Preparation, Characterization and Exploring the Anti-leishmanial Activity

Year 2025, Volume: 55 Issue: 2, 149 - 159, 23.09.2025

Emine Dilek Özyılmaz , Emrah Güler , Kaya Süer , Ahmet Özbilgin , İbrahim Çavuş , Tansel Çomoğlu

https://doi.org/10.26650/IstanbulJPharm.2025.1634744

Abstract

Background and Aims: This study investigated the potential of naltrexone hydrochloride (NH) loaded water-in-oil (W/O) microemulsions (ME) as an alternative treatment strategy for cutaneous leishmaniasis caused by Leishmania tropica. This study aims to provide a topical alternative to the treatment of leishmaniasis, while also identifying a new therapeutic use of naltrexone other than its use in opioid addiction.

Methods: Stable water-in-oil microemulsion formulations were developed using linseed oil, Span 60®, and polyethylene glycol 400. Microemulsions were prepared using triangle phase diagrams and optimization was performed by determining the droplet size, viscosity, pH, conductivity, and zeta potential values. The antileishmanial activity of the optimized microemulsion formulation was tested under in vitro conditions.

Results: The optimized formulation (ME-2) demonstrated favorable physicochemical properties, including a droplet size of 99.86 nm, low polydispersity index (0.242), and high zeta potential (-42.9 mV), ensuring stability and homogeneity. In vitro release studies indicated first-order kinetics, suggesting the controlled release of NH. The antileishmanial activity of ME-2 was evaluated against L. tropica promastigote, revealing a 50% inhibition at an IC50 concentration of 5.17 µM. While amphotericin B, the gold standard, exhibited superior efficacy (IC50 = 0.063 µM), NH demonstrated a dose-dependent reduction in promastigote viability. This suggests its potential as a supplementary treatment, particularly in cases where amphotericin B's toxicity is a concern.

Conclusion: Future studies focusing on structural optimization, mechanism elucidation, and in vivo validation could enhance NH’s efficacy, offering a promising alternative for leishmaniasis management. This work establishes a foundational basis for leveraging NH microemulsions in parasitic disease therapy.

Keywords

Anti-leishmanial Activity , Drug Release Kinetics , Microemulsions , Naltrexon HCl , Stability

References

• Abd Sisak, M.A., Daik, R., & Ramli, S. (2017). Study on the effect of oil phase and co-surfactant on microemulsion systems. Malaysian Journal of Analytical Sciences, 21:1409-1416. google scholar
• Al-Mohaimeed, A.M., Mostafa, G.A., & El-Tohamy, M.F. (2021). New construction of functionalized CuO/Al2O3 nanocomposite-based polymeric sensor for potentiometric estimation of naltrexone hydrochloride in commercial formulations. Polymers, 13(24), 4459. google scholar
• Arya, R., Dhembla, C., Makde, R.D., Sundd, M., & Kundu, S. (2021). An overview of the fatty acid biosynthesis in the protozoan parasite leishmania and its relevance as a drug target against leishmaniasis. Molecular and Biochemical Parasitol- ogy. 246, 111416. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20533 google scholar
• Chang, L., Pope, G.A., Jang, S.H., & Tagavifar, M. (2019). Prediction of microemulsion phase behavior from surfactant and co-solvent structures. Fuel., 237, 494-514. google scholar
• Choubey, A., Dehury, B., Kumar, S., Medhi, B., & Mondal, P. (2022). Naltrexone a potential therapeutic candidate for COVID-19. Journal of Biomolecular Structure and Dynamics, 40(3), 963-970. google scholar
• da Silva, S.S.S., de Andrade, A.F., de Paiva-Cavalcanti, M., de Carvalho, J.C.M., de Araújo Viana-Marques, D., Porto, A.L.F., & Bezerra, R.P. (2023). Potential of bioactive molecules from photosynthetic microorganisms on Leishmania spp.: A review. Algal Research, 103241. google scholar
• de Vries, H.J., & Schallig, H.D. (2022). Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. American Journal of Clinical Dermatology, 23(6), 823-840. google scholar
• Eser, M., & Çavuş, İ. (2023). In vitro and in silico evaluations of the antileishmanial activities of new benzimidazole-triazole derivatives. Veterinary Sciences and Practices, 10: 648. google scholar
• Ghosh, P., Roy, P., Chaudhuri, S.J., & Das, N.K. (2021). Epidemiology of post-kala-azar dermal leishmaniasis. Indian Journal of Dermatology, 66(1), 12-23. google scholar
• Gigloo, A.L., Sarkari, B., Rezaei, Z., Hatam, G.R., & Davami, M.H. (2018). Asymptomatic leishmania infected children: A seroprevalence and molecular survey in a rural area of fars province, southern Iran. Journal of Tropical Medicine, 8167247. google scholar
• Güler, E., Özbilgin, A., Çavuş, İ., Baddal, B., Etikan, İ., & Başer, K.H.C., Şanlıdağ, T. (2021). In vitro Anti-leishmanial activity of essential oils extracted from plants growing in northern cyprus against leishmania tropica. Turkiye Parazitoloji Dergisi,. 45(2), 101-107. google scholar
• Gürel, M.S., Yeşilova, Y., Ölgen, M.K., & Özbel, Y. (2012). Cutaneous leishmaniasis in Turkey. Turkiye Parazitoloji Dergisi, 36, 121-129. google scholar
• Hendrickx, S., Van den Kerkhof, M., Mabille, D., Cos, P., Delputte, P., Maes, L., & Caljon, G. (2017). Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum. PLoS neglected tropical diseases, 11(5), e0005620. google scholar
• Hu, Y., Liu, L., Zhang, X., Feng, Y., & Zong, Z. (2017). In vitro activity of neomycin, streptomycin, paromomycin and apramycin against carbapenem-resistant Enterobacteriaceae clinical strains. Frontiers in Microbiology, 8: 2275. google scholar
• Kelty, E., Hulse, G., Joyce, D., & Preen, D.B. (2020). Impact of pharmacological treatments for opioid use disorder on mortality. CNS drugs, 34, 629-642. google scholar
• Khorsandi, S., & Johns, R.T. (2016). Robust flash calculation algorithm for microemulsion phase behavior. Journal of Surfactants and Detergents. 19, 1273-1287. google scholar
• Madusanka, R.K., & Silva, H. (2022). Treatment of cutaneous leishmaniasis and insights into species-specific responses: A narrative review. Infectious Diseases and Therapy, 11, 695-711. google scholar
• Murphy, A., Barbaro, J., Martínez-Aguado, P., Chilunda, V., Jaureguiberry-Bravo, M., & Berman. J.W. (2019). The effects of opioids on HIV neuropathogenesis. Frontiers in immunology, 10, 2445. google scholar
• Özbilgin, A., Çavuş, İ., Yıldırım, A., & Gündüz, C. (2018). Do the rodents have a role in transmission of cutaneous leishmaniasis in Turkey? Mikrobiyoloji Bülteni, 52(3), 259-272. google scholar
• Özdoğaç, M., Güler, E., Güvenir, M., Hürdoğanoğlu, U., Kiraz, A., & Süer, K. (2022). Investigation of Leishmania infantum seroprevalance and leishmaniasis knowledge level in northern cyprus. Mikrobiyoloji Bülteni, 56(3), 377-386. google scholar
• Özyilmaz, E.D., Sayıner, Ö., & Çomoglu, T. (2020). Mikro ve nanoemülsiyonların far-masötik yönden değerlendirilmesi. Journal of Literature Pharmacy Sciences, 9(1), 65-76. google scholar
• Ram, K.P., & Sameer, S.K. (2020). Effect of surfactants and co-surfactants on phase behaviour and physicochemical properties of self-nanoemulsifying drug delivery system loaded with plumbagin. Global Journal of Pharmacy & Phar- maceutical Sciences, 10, 1-11 google scholar
• Rebouças, L.M., Melo, T.M., Silva, M.S.P., Santos, E.M.A., & Ricardo, N.M. (2024). Nanoemulsions based on linseed oil containing encapsulated ethyl butylacetylaminopropionate for repellent application. Journal of Applied Pharma- ceutical Sciences and Research, 6(4), 12-17. google scholar
• Rowe, R.C., Sheskey, P., & Quinn, M. (2009). Handbook of pharmaceutical excipients. Libros Digitales-Pharmaceutical Press. google scholar
• Ruh, E., & Taylan Özkan, A. (2019). Leishmaniasis in northern cyprus. European Journal of Therapeutics, 25 (1), 1-5. https://doi.org/10.5152/EurJTher.2019.18077 google scholar
• Scarpini, S., Dondi, A., Totaro, C., Biagi, C., Melchionda, F., Zama, D., Pierantoni, L., Gennari, M., Campagna, C., Prete, A., & Lanari, M. (2022). Visceral leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics. Microorganisms, 10, 1887. google scholar
• Siddique, M.Y., Nazar, M.F., Saleem, M.A., Haider, S., Sumrra, SH, Akhtar MS, Farooqi ZH. Formulation of gelled microemulsion for effective permeation of celecoxib across the skin barrier. ChemistrySelect. 2024; 9(3): e202302841. google scholar
• Sisko-Kraljevic. K., Jeroncic, A., Mohar, B., & Punda-Polic, V. (2013). Asymptomatic Leishmania infantum infections in humans living in endemic and nonendemic areas of croatia, 2007 to 2009. Euro Surveill, 18(29), 20533. google scholar
• Souto, E.B., Cano, A., Martins-Gomes, C., Coutinho, T.E., Zielińska, A., S& ilva, A.M. (2022). Microemulsions and nanoemulsions in skin drug delivery. Bioengineering, 9(4), 158. google scholar
• Ware, P., Yadav, G., Jain, A., & Tambvekar, O. (2024). Formulation and evaluation of microemulsion based itraconazole gel: formulation and evaluation of microemulsion based itraconazole gel. Journal of Drug Delivery and Biother- apeutics, 2(01), 42-71. google scholar
• Zhang, H., Xia, J., Ding, C., Xu, B., Wang, S., Wu, Z., Zhao, W. (2023). The formation and temperature stability of microemulsion emulsified by polyoxyethylene ether surfactant. Progress in Natural Science: Materials International, 33(3), 295-300. google scholar